CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 80 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,410,425 | +27.9% | 161,665 | -6.0% | 0.00% | 0.0% |
| Q2 2023 | $1,884,024 | +228.6% | 172,057 | +161.7% | 0.00% | +100.0% |
| Q1 2023 | $573,305 | +258.3% | 65,746 | +86.4% | 0.00% | – |
| Q1 2021 | $160,000 | -29.2% | 35,269 | -10.6% | 0.00% | – |
| Q4 2020 | $226,000 | -86.8% | 39,466 | -91.9% | 0.00% | -100.0% |
| Q2 2020 | $1,711,000 | +88.6% | 490,223 | -19.9% | 0.00% | 0.0% |
| Q1 2020 | $907,000 | +1195.7% | 612,290 | +1624.3% | 0.00% | – |
| Q4 2019 | $70,000 | -70.6% | 35,509 | -23.8% | 0.00% | – |
| Q3 2019 | $238,000 | -23.5% | 46,594 | +6.9% | 0.00% | – |
| Q2 2019 | $311,000 | -97.2% | 43,589 | -94.7% | 0.00% | -100.0% |
| Q1 2019 | $11,024,000 | +3355.8% | 830,107 | +1949.0% | 0.01% | – |
| Q4 2018 | $319,000 | -29.6% | 40,513 | -1.1% | 0.00% | – |
| Q3 2018 | $453,000 | -41.9% | 40,943 | -29.6% | 0.00% | -100.0% |
| Q2 2018 | $780,000 | +179.6% | 58,152 | +170.6% | 0.00% | – |
| Q1 2018 | $279,000 | +3.0% | 21,489 | -27.0% | 0.00% | – |
| Q4 2017 | $271,000 | +113.4% | 29,435 | +85.8% | 0.00% | – |
| Q3 2017 | $127,000 | – | 15,842 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
| COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
| Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
| Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
| Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
| Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
| ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
| CM Management, LLC | 150,000 | $681,000 | 0.51% |
| APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
| Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |